Red Earth Cannabis

- A premier state of the art Cannabis infused product development, manufacturing and packaging company.
RED EARTH CANNABIS
Private Label Manufacturing
Applying the robust manufacturing methods our North American consumer economy relies on and leveraging them to establish the best-in-
class benchmarks to the supply chain of a growing market.

This corporate document contains “forward-looking statements” and “forward-
looking information” (collectively, “forward-looking information”) within the
meaning of applicable securities legislation.” Thereafter, all references should
be to “forward-looking information”). This corporate document may use words
such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”,
“intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, and other similar
expressions to identify forward-looking statements. Actual results, performance
or achievement could differ materially from that expressed in, or implied by,
any forward-looking statements in this corporate document, and, accordingly,
investors should not place undue reliance on any such forward-looking
statements. Forward-looking information involves significant risks, assumptions,
uncertainties and other factors that may cause actual future results or
anticipated events to differ materially from those expressed or implied in any
forward-looking statements and accordingly, should not be read as guarantees
of future performance or results. Any forward-looking statements speak only as
of the date on which such statement is made and each of the Company and the
Agents disclaims any intention or obligation to update or revise any forward-
looking information, where as a result of new information, future events or
otherwise, unless required by applicable law. New factors emerge from time to
time, and it is not possible for management to predict all of such factors and to
assess in advance the impact of each such factor on the Company’s business or
the extent to which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any forward-looking
statements.
Forward looking Statements Legal Disclaimer
This document provides a description of Stigma Pharmaceutical its affiliates (together,
the “Company”)and their respective businesses. Prospective investors are encouraged to
obtain independent legal advice concerning any investment in securities of the Company
and should not base their decision on whether to invest in the Company solely upon the
material provided herein. There are no representations or warranties made herein by the
Company or the agents, if any, of the proposed offering of any securities or debt
instruments in the Company (the “Agents”) and investors will only be able to rely on the
representations and warranties contained in the subscription agreement to be entered
into at the time of sale of the securities. There are certain risks inherent in an investment
in the securities of the Company that prospective investors should carefully consider
before investing in the securities of the Company. This document constitutes an offering
of the securities described herein only in those jurisdictions and to those persons where
and to whom they may be lawfully offered for sale, and only by persons permitted to sell
these securities. This document is not, and under no circumstances is it to be construed
as, an advertisement or a public offering of these securities. This document is personal to
each offeree and does not constitute an offer to any other person or to the public
generally to subscribe for or otherwise acquire any of the securities referred to herein. No
securities regulatory authority or similar authority has reviewed or in any way passed
upon the presentation or the merits of these securities and any representation to the
contrary is an offence. This document has been prepared for information purposes only
in order to assist prospective investors in evaluating an investment in the Company. No
representation, warranty or undertaking, express or implied, is made and no responsibility
or liability is accepted by the Agents as to the accuracy or completeness of the
information contained herein or any other information, representation, warranty or
undertaking, express or implied, made by the Company in connection with the offering of
securities described herein.
FORWARD LOOKING STATEMENT
2

Dr.Tyler Macdonald
(President and Founder)
BRAIN THRUST AND EXECUTION
• Multiple asset-backed capital
raises
• 10 years of project management
experience
• Administering quality assurance
programs
• ACMPR designated cannabis
grower
Trevor MacMillan
(Chief Science Officer)
• Expert in plant biology
• Cannabis growing and plant
extractions
• Industry experienced in growing
under the Health Canada
ACMPR
Daniel Hughes
(Chief Operating Officer)
• Distribution oversight Pepsi
Canada
• Well experienced in
manufacturing of products
Katie MacDonald
(EVP Quality Assurance)
• Quality assurance Canada Island
Garden (LP)
• Quality assurance Bio-Vectra
pharmaceutical
Jeremy Stiles
(Advisory Quality and
Regulatory)
• 20 Years as pharmaceutical
quality assurance
• Has worked with Health Canada
to bring drugs to the market
• Great understanding of the
ACMPR regulations
3

Core Activity
Manufacturing specialist for Cannabis
infused contract product processing and
premier packaging. Our goal is to be
considered a partner and extension of our
customer by working with them as a cohesive
unit to get their products to the market place
with quality and efficiency.
Innovation Advantage
Overlooked long term storage, enterprise
resource planning and white-label
manufacturing, through the adoption of
forward looking advances in processing
equipment and software.
NOT A GROWER, A VALUE ADDED
PARTNER
4

• The current race has been
focused first-to-grow,
leading towards an eventual
overproduction as seen in
past pre-commodity crops.
• Ancillary services have
remained unattended to,
creating an nationwide
bottleneck for value-added
products.
THE LANDSCAPE
The Cannabis Industry is
rapidly evolving towards its
place amongst the
consumer economy:
• The creation of national
distribution agreements.
• Brand licensing opportunities
and cross-border advertising.
As the market is refined
relationships between buy
and sell sides tighten:
• Members of the International
Narcotics Control Board are
jumping at the opportunity of a
new tax base and Canada is the
lead example and hub for
training, import-export and
transformation.
The globe is Cannabis:
5

DO YOU PARTNER WITH THE SUGAR FARMER? WHY WOULD YOU DO THE
SAME FOR CANNABIS
6

https://www.statista.com/statistics/820158/global-legal-cannabis-market/
https://www.forbes.com/sites/mikemontgomery/2017/07/19/edibles-are-the-next-big-thing-for-pot-entrepreneurs/#6afab2d8576b
MARKET DATA
• Cannabis industry insiders
are so busy securing capital
to build that the SCM model
is completely overlooked.
• In California alone, consumers
gobbled up more than $180
million worth of marijuana-
infused food and drinks last
year,10% of the state’s cannabis
sales.
• Overall the smoking rate among
adults is down from 20.6% in
2009 to 16.8% in 2014.
• And since Colorado first allowed
recreational marijuana use, sales
tripled from $17 million in the first
quarter of 2014 to $53 million in
the third quarter of 2016.[2]
• This statistic shows the
projected spending on legal
cannabis worldwide from 2016
to 2024. By 2024, spending on
legal cannabis is expected to
reach 63.5 billion U.S. dollars
worldwide.[1]
• Canada alone is expecting 30
billion CDN before 2020.
7
Cannabis is set to hit
$75 billion globally
Processed Cannabis is the
next massive growth curve.
There are currently no
implemented cannabis centric
Private Label Manufacturers

POTENTIAL CONTRACT MANUFACTURING PRODUCT PORTFOLIO
8

ACCESS TO THE LARGEST MARKETS GLOBALLY
9

We are not reinventing the
wheel, simply, adapting it to
Cannabis. Our state of the art
contract manufacturing and
packaging facility will allow
for development of new age
Cannabis infused products.
10

Providing
scalability
and quick
access to the
market for
your
products.
11

Immediate
procurement of top-
tier ERP technology,
manufacturing
equipment and the
best personal in the
niche.
Securing binding LOIs
with established
brands both within
the Cannabis industry
and the mainstream
ones preparing an
entry.
12

ERPENTERPRISE RESOURCE
PLANNING
CUSTOMER WEB
PORTAL CRM & SALES
DISTRIBUTION
TIME & PROJECTS
DASHBOARDS
FINANCE
MANUFACTURING
PURCHASING
13

First-to-market
advantage by
establishing best
industry practices,
attracting mainstream
brands.
14

Best Practice
Services
15
RED EARTH

Executive
Officers
QI/Q
A
Product
Development
Administration Business
Development
Logistics and
Operations
Engineering
and
Automation
THE PERSONNEL
16

STRATEGIC PARTNERS
17

CAPITAL FORMATION
November
2018
December 2018
Q4
2018
SEED Round Open
Q4
2018
SEED Round Close
Q1
2019
Round 1 Begins
Q2
2019
Round 1
close
Q2
2020
IPO launch
18

$775,000
1.
Deposit for the
Equity Swap
$375,00
0
$100,00
0
2.
Design and
Consulting / Build
$200,00
0
3.
CSE filing / Legal /
Accounting
$100,00
0
4.
Round A Capital
raise
USE OF
PROCEEDS
FFBA ROUND
19

THE OFFER – FFBA ROUND
01 23% Stake
0
2
Entry Price
• $0.30 per share
0
3
Bonus
• 1:3 - $0.60 per
warrant
20

24 month run
rate
1. Extraction and
production equipment
$6
Million
$1,000,00
0 $1,500,00
0
USE OF
PROCEEDS
$3,500,000
ROUND A
21
Cost building,
16,000 sq.ft

THE OFFER – ROUND A
01 44% Stake
0
2
Entry Price
• $0.60 per share
0
3
Bonus
• 1:3 - $1.20 per warrant
22

FINANCIAL HIGHLIGHTS – THE CAP TABLE
NUMBER OF SHARES PRICE % AMOUNT %
FFBA Q3 2018
Founders
(Dr.Tyler & Alecia)
7,800,000.00 $0.0023 75.91% $17,940.00 88.89%
ZERO404 975,000.00 $0.0023 9.49% $2,242.50 11.11%
Options 1,500,000.00 $0.0023 14.60% 0.00%
Total 10,275,000.00 100.00% $20,182.50 100.00%
SEED Q4 2018
SEED 1,333,333.33 $0.30 10.37% $400,000.00 11.74%
Land Swap 1,250,000.00 $0.30 9.72% $375,000.00 11.01%
Founders
(Dr.Tyler & Alecia)
7,800,000.00 $0.30 60.66% $2,340,000.00 68.67%
ZERO404 975,000.00 $0.30 7.58% $292,500.00 8.58%
Options 1,500,000.00 $0.30 11.67% 0.00%
Total 12,858,333.33 100.00% $3,407,500.00 100.00%
23

NUMBER OF SHARES PRICE % AMOUNT %
ROUND 1 Q2 2019
SEED 1,333,333.33 $0.60 5.83% $800,000.00 5.83%
Equity Swap 1,250,000.00 $0.60 5.47% $750,000.00 5.47%
Round 1 10,000,000.00 $0.60 43.75% $6,000,000.00 43.75%
Founders
(Dr.Tyler & Alecia)
7,800,000.00 $0.60 34.12% $4,680,000.00 34.12%
ZERO404 975,000.00 $0.60 4.27% $585,000.00 4.27%
Options 1,500,000.00 $0.60 6.56% $900,000.00 6.56%
Total 22,858,333.33 100.00% $13,715,000.00 100.00%
IPO Q2 2020
SEED 1,333,333.33 $1.00 2.79% $1,333,333.33 2.79%
Equity Swap 1,250,000.00 $1.00 2.61% $1,250,000.00 2.61%
Round 1 10,000,000.00 $1.00 20.90% $10,000,000.00 20.90%
Founders
(Dr.Tyler & Alecia)
7,800,000.00 $1.00 16.30% $7,800,000.00 16.30%
ZERO404 975,000.00 $1.00 2.04% $975,000.00 2.04%
Options 1,500,000.00 $1.00 3.13% $1,500,000.00 3.13%
Round 2 25,000,000.00 $1.00 52.24% $25,000,000.00 52.24%
Total 47,858,333.33 100.00% $47,858,333.33 100.00%
24

REVENUE FORECAST
California, edibles and
concentrates claimed 37%
of the total marijuana
market. [4]
The Canadian Cannabis Economy as a whole in
2019 - $7 billion[3]
The Edibles Category has reached 35% stateside - $2.45 billion
We plan on 5% of $2.4 billion - $122,500,000
Contract Packaging Industry enjoys a 35% gross margin.
Forecasted Revenue - $35,000,000 in Year
2.
https://www.fool.com/investing/2018/07/22/the-massive-marijuana-market-you-wont-see-in-canad.aspx
https://www2.deloitte.com/content/dam/Deloitte/ca/Documents/consulting/ca-cannabis-2018-report-en.PDF
25

- A premier state of the art Cannabis infused product development, manufacturing and packaging company. 26
MARKET COMPARABLES
Name Symbol Market Cap
*CDN$
Share Price
*CDN$
Sales
Last Q
Revenue
(Annual
Revenue)
P/
Sales*
Beleave CSE:BE $55,733,834[5] $0.94 $208,651 $834,604 66.77
Sunniva Inc. CSE:SNN $180,664,000[6] $4.96 $4,469,000 $16,072,000
(as on 31.12.2017)
11.24
Nutritional High
International Inc.
CSE:EAT $72,804,000[7] $0.25 $1,966,400 $660,222
(as on 31.07.2017)
110
Red Earth $140 million $5 million $20 million 7x
(Three months
ended- June
30,2018)
(Three months
ended- June
30,2018)
(Three months
ended- April
30,2018)
https://thecse.com/en/search/node/BE
https://finance.yahoo.com/quote/SNN.CN/financials?p=SNN.CN&.tsrc=fin-srch
https://finance.yahoo.com/quote/EAT.CN/financials?p=EAT.CN

Red Earth Cannabis

Recommended

Recommended

More Related Content

What's hot

What's hot (17)

Similar to Red Earth Cannabis

Similar to Red Earth Cannabis (20)

Recently uploaded

Recently uploaded (11)

Red Earth Cannabis